Tumour-to-tumour metastasis: a rare case of prostate cancer metastasising to primary lung adenocarcinoma

Autor: Rachelle Hamadi, Imad Karam, Salman Khan, Sylvester Homsy, Carol Luhrs

Publikováno v: European Journal of Case Reports in Internal Medicine (2024)

Tumour-to-tumour metastasis (TTM) is a rare phenomenon that clinicians should be aware of when evaluating patients with a history of prostate cancer. We present the diagnosis and management of an 80-year-old former smoker with high-risk prostate canc

Externí odkaz: https://doaj.org/article/2fa7c5b9f6844a5d9c3378abac6a2c0b

83 The prognostic significance of peripheral blood biomarkers in patients with advanced non-small cell lung cancer treated with pembrolizumab: a clinical study

Autor: Kira MacDougall, Muhammad Niazi, Jeff Hosry, Sylvester Homsy, Alexander Bershadskiy

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

Externí odkaz: https://doaj.org/article/9f305414aad84fb9843e8a3714728982

The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study

Autor: Kira, MacDougall, Muhammad Rafay Khan, Niazi, Jeff, Hosry, Sylvester, Homsy, Alexander, Bershadskiy

Publikováno v: ONCOLOGY.

Systemic inflammation has long been associated with poor outcomes in many types of solid tumors. Peripheral blood biomarkers, such as absolute lymphocyte count (ALC) and the ratio of absolute neutrophil count to absolute lymphocyte count (ANC/ALC), h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37da8c817110160e4e0080ab07138a3
https://doi.org/10.46883/25920954

Recurrent Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma with Meningeal Involvement

Autor: Mark Raden, Yevgeniy Skaradinskiy, Ralph Kamel, Sylvester Homsy

Publikováno v: Case Reports in Hematology
Case Reports in Hematology, Vol 2021 (2021)

Extranodal natural killer/T-cell lymphoma nasal type (NNKTL) is a type of non-Hodgkin’s lymphoma that has been associated with Epstein–Barr virus (EBV). It has an aggressive behavior, known for predilection to metastasize to different organs. Cen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e547d9fe58b16d509eee8f448b5eef72
http://europepmc.org/articles/PMC8328685

Bevacizumab-Induced Pneumonitis in a Patient With Metastatic Colon Cancer: A Case Report

Autor: Dany Elsayegh, Sylvester Homsy, Sami Pervaiz, Naureen Narula, Sam Ngu

Publikováno v: Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 14 (2020)

Bevacizumab is a vascular endothelial growth factor–directed humanized monoclonal antibody used to treat many types of cancer and some eye diseases. Due to inhibition of angiogenesis, many adverse reactions such as bowel necrosis, nasal septal perf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebcaf8219fc4cfa4684d1b189d2127a1
https://doi.org/10.1177/1179548420929285